Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
2024 · Nature Cancer · 77 citations
https://doi.org/10.1038/s43018-024-00725-0
D
Ding Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
371
Citations
7
h-index
7
i10-index
Ding Ma is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Computational Drug Discovery Methods. The author has an h-index of 7, co-authored 33 publications.
ORCID: 0009-0000-4890-6424Papers by this author
worksMolecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024 · Cancer Research · 37 citations
https://doi.org/10.1158/0008-5472.can-23-4066
A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19783498
Table S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27603352
Table S5 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27603340
Figure S7 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27603361
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat